Research status and progress of Glypican-3 and liver carcinoma
10.3760/cma.j.issn.1009-9158.2020.02.018
- VernacularTitle: Glypican-3与肝癌关系的研究现状与进展
- Author:
Meichen DONG
1
;
Qi LI
2
;
Xiangyi LIU
1
Author Information
1. Department of Laboratory Medicine, Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100730, China
2. Department of Laboratory Medicine, Xiyuan Hospital, China Academy of Chinese Medical Science, Beijing 100091, China
- Publication Type:Review
- Keywords:
Liver neoplasms;
Glypicans;
Biomarkers, tumor;
Prognosis
- From:
Chinese Journal of Laboratory Medicine
2020;43(2):199-202
- CountryChina
- Language:Chinese
-
Abstract:
Phosphatidylinositol protein 3 (Glypican-3, GPC3) is a cell-surface heparan sulfate proteoglycan that belongs to the glycine related global membrane proteoglycan relatives.Many studies have shown that it is of great significance in the occurrence, diagnosis, treatment and prognosis of hepatocellular carcinoma (HCC).This paper reviews the recent studies on GPC3.
